Wird geladen...
Protein kinase C beta (PKCβ) in malignant pleural mesothelioma
PURPOSE: Malignant pleural mesothelioma (MPM) is a disease with few therapeutic options. Protein kinase C beta (PKCß) is involved in important cellular functions. Enzastaurin (LY317615.HCl) is a novel inhibitor of PKC in clinical development. EXPERIMENTAL DESIGN: MPM cell lines (7) and patient tumor...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2605682/ https://ncbi.nlm.nih.gov/pubmed/18765998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e32830ce506 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|